Pet companies widen manufacturing footprints across key markets
Bottom line
Pet food manufacturers are widening their production footprints across China, Australia, Europe, and the US as they try to get closer to demand, reduce logistics risk, and add capacity in faster-growing segments like wet food. GlobalPETS highlighted moves by companies including BEWITAL, which opened a wet pet food facility in Weihai, China, for the local market, and Nestlé Purina, which is adding major new capacity in Italy and has just opened a new factory in Ohio. In Australia, Mars opened a A$112.6 million wet cat food facility in Wodonga in June, part of a broader A$200 million manufacturing investment through 2027. (globalpetindustry.com)
Why it matters: For veterinary professionals, these investments are a supply-chain story with clinical implications. More local and regional manufacturing can improve product availability, shorten replenishment times, and reduce reliance on imports for therapeutic, premium, and wet formats that many clinics and pet parents increasingly use. At the same time, more localized production may bring formulation changes, new SKUs, and country-specific launches, so practices may want to watch sourcing, continuity, and any shifts in nutrition portfolios tied to regional plants. (mars.com)
What to watch: Watch for additional factory openings, line expansions, and localization announcements, especially in China and wet-food categories, as companies translate capital spending into new products and wider veterinary-channel availability. (royalcanin.com.cn)
A new round of manufacturing expansion shows how major pet companies are reshaping their supply chains across key markets. GlobalPETS reports that companies including BEWITAL, Nestlé Purina, Freshpet, and others are investing in production, storage, and distribution capacity from China to Australia, reflecting a broader push to meet demand more efficiently and reduce supply friction. (globalpetindustry.com)
Several of the moves center on a familiar industry challenge: demand has grown, but so has the need for resilience. In recent years, pet food makers have had to navigate freight volatility, ingredient constraints, trade complications, and changing local regulatory requirements. China remains a strategically important market for global pet businesses, with prior GlobalPETS reporting showing that many companies still see the country as central to growth even as they reassess how they manufacture and distribute there. (globalpetindustry.com)
Among the clearest examples is BEWITAL’s new wet pet food facility in Weihai, China, its first production plant outside Germany, according to trade reporting. GlobalPETS said the site is dedicated to wet food for the local market, while related coverage indicates the project had been in motion since 2023 and is expected to employ about 50 people by year-end. The strategy appears straightforward: keep German production for some products where regulations allow, while building in-market capacity for speed, localization, and supply continuity. (globalpetindustry.com)
Nestlé Purina is making similarly large bets on regional production. In July, Nestlé said it will invest CHF 520 million in a new integrated plant and logistics platform in Mantova, Italy, with operations expected to begin in 2029. The company said the site will produce super-premium wet food for cats and dogs and improve logistics efficiency and transport flows across Europe. Weeks later, Purina officially opened its new Batavia, Ohio, factory, a more than $550 million investment that the company described as its first brand-new US factory built from the ground up since 1975. (nestle.com)
Australia is part of the same map. Mars opened a A$112.6 million wet cat food facility in Wodonga, Victoria, on June 11, 2026, saying the plant will produce 290 million pouches annually and help bring the share of Mars pet care products sold in Australia and New Zealand that are made locally to 90%. The opening followed Mars’ previously announced A$200 million investment in Australian manufacturing through 2027. That matters in a market where official Canadian trade analysis estimated Australian pet food retail sales reached US$2.9 billion in 2024, with steady growth and continued product launches. (mars.com)
There are also signs that China localization is accelerating beyond one company. Royal Canin China said in late August that it had signed a memorandum of understanding with Tianjin authorities to deepen investment at its Tianjin factory, including expansion and technology upgrades for dry and wet food lines, product innovation, greener operations, and stronger supply-chain resilience. Chinese reports also indicate the wet line is now operational, giving Royal Canin a dual-factory footprint spanning Tianjin and Shanghai. (royalcanin.com.cn)
Why it matters: For veterinary professionals, these capital projects are more than corporate footprint stories. Manufacturing closer to end markets can improve availability, reduce lead times, and lower the risk of disruptions that affect everyday nutrition products as well as specialty diets used in clinical care. Expansion in wet food is especially notable because that format is growing quickly in multiple regions and often plays an outsized role in palatability, hydration support, and condition-specific feeding plans. Still, local production can also mean phased portfolio shifts, new packaging, or reformulated products tailored to regional sourcing and consumer demand, so clinics and distributors may need to stay alert to continuity issues and product-transition questions from pet parents. (nestle.com)
What to watch: The next phase is whether these investments translate into measurable gains in fill rates, new product launches, and stronger veterinary-channel supply. Near term, watch for more announcements tied to China localization, Australian capacity buildout through 2027, and Purina’s longer-dated European timeline toward its planned 2029 start in Mantova. (royalcanin.com.cn)